Author Tzvetkov, Mladen Vassilev
-
2003 | Journal Article
Genetic dissection of trehalose biosynthesis in Corynebacterium glutamicum: inactivation of trehalose production leads to impaired growth and an altered cell wall lipid composition
Tzvetkov, M. V.; Klopprogge, C.; Zelder, O. & Liebl, W. (2003)
Microbiology, 149 pp. 1659-1673. DOI: https://doi.org/10.1099/mic.0.26205-0
Details DOI PMID PMC WoS
-
2004 | Conference Abstract
Association of NAD(P)H oxidase and MRP genetic polymorphisms with doxorubicin-induced cardiotoxicity
Wojnowski, L.; Schluter, G.; Vonhof, S.; Kulle, B.; Bickeboeller, H. ; Toliat, M. R. & Suk, E. K. et al. (2004)
Naunyn-Schmiedeberg s Archives of Pharmacology, 369 45th Spring Meeting of the German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology, Mainz, GERMANY.
New york: Springer.
Details WoS
-
2004 | Conference Abstract
NAD(P)H oxidase and MRP genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
Schirmer, M. A.; Wojnowski, L.; Schluter, G.; Vonhof, S.; Kulle, B.; Bickeboeller, H. & Toliat, M. R. et al. (2004)
Circulation, 110(17) pp. 807-808. 77th Scientific Meeting of the American-Heart-Association, New Orleans, LA.
Philadelphia: Lippincott Williams & Wilkins.
Details WoS
-
2004 | Journal Article
Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics
Kirchheiner, J.; Heesch, C.; Bauer, S.; Meisel, C.; Seringer, A.; Goldammer, M. & Tzvetkov, M. V. et al. (2004)
Clinical Pharmacology & Therapeutics, 76(4) pp. 302-312. DOI: https://doi.org/10.1016/j.clpt.2004.07.002
Details DOI PMID PMC WoS
-
2005 | Journal Article
Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets
Kirchheiner, J.; Henckel, H. B.; Franke, L.; Meineke, I.; Tzvetkov, M. V.; Uebelhack, R. & Roots, I. et al. (2005)
Pharmacogenetics and Genomics, 15(8) pp. 579-587.
Details PMID PMC WoS
-
2005 | Conference Abstract
Hydrochlorothiazide and polymorphisms in the angiotensin I converting enzyme, alpha adducin and the G-protein subunit beta 3 in healthy volunteers
Vormfelde, S. V.; Sehrt, D.; Tzvetkov, M. V. & Brockmoeller, J. (2005)
European Journal of Clinical Pharmacology, 61(9) pp. 698-699. 7th Annual Congress of Clinical Pharmacology, Dresen, GERMANY.
New york: Springer.
Details WoS
-
2005 | Conference Abstract
Differential sensitivity to doxorubicin-induced cardiotoxicity in two inbred mouse strains
Wojnowski, L.; Seifert, S.; Schmidt, A.; Kulle, B.; Brockmoeller, J.; Tzvetkov, M. V. & Hahn, H. (2005)
Naunyn-Schmiedeberg s Archives of Pharmacology, 371 46th Spring Meeting of the Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und Toxikologie, Mainz, GERMANY.
New york: Springer.
Details WoS
-
2005 | Journal Article
Genome-wide single-nucleotide polymorphism arrays demonstrate high fidelity of multiple displacement-based whole-genome amplification
Tzvetkov, M. V.; Becker, C.; Kulle, B.; Nurnberg, P.; Brockmoeller, J. & Wojnowski, L. (2005)
Electrophoresis, 26(3) pp. 710-715. DOI: https://doi.org/10.1002/elps.200410121
Details DOI PMID PMC WoS
-
2006 | Journal Article
Topoisomerase II beta expression level correlates with doxorubicin-induced apoptosis in peripheral blood cells
Kersting, G.; Tzvetkov, M. V.; Huse, K.; Kulle, B.; Hafner, V.; Brockmoeller, J. & Wojnowski, L. (2006)
Naunyn-Schmiedeberg s Archives of Pharmacology, 374(1) pp. 21-30. DOI: https://doi.org/10.1007/s00210-006-0091-0
Details DOI PMID PMC WoS
-
2006 | Journal Article
Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers
Vormfelde, S. V.; Sehrt, D.; Bolte, D.; Pahl, S.; Tzvetkov, M. V. & Brockmoeller, J. (2006)
European Journal of Clinical Pharmacology, 62(3) pp. 195-201. DOI: https://doi.org/10.1007/s00228-005-0081-z
Details DOI PMID PMC WoS
-
2007 | Journal Article
Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine
Tzvetkov, M. V.; Meineke, C.; Oetjen, E.; Hirsch-Ernst, K. I. & Brockmoeller, J. (2007)
Gene, 386(1-2) pp. 52-62. DOI: https://doi.org/10.1016/j.gene.2006.08.002
Details DOI PMID PMC WoS
-
2007 | Journal Article
Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication
Kirchheiner, J.; Schmidt, H.; Tzvetkov, M. V.; Keulen, J.-T.; Loetsch, J.; Roots, I. & Brockmoeller, J. (2007)
The Pharmacogenomics Journal, 7(4) pp. 257-265. DOI: https://doi.org/10.1038/sj.tpj.6500406
Details DOI PMID PMC WoS
-
2007 | Journal Article
Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugs
Vormfelde, S. V.; Sehrt, D.; Toliat, M. R.; Schirmer, M. A.; Meineke, I.; Tzvetkov, M. V. & Nuernberg, P. et al. (2007)
Clinical Pharmacology & Therapeutics, 82(3) pp. 300-309. DOI: https://doi.org/10.1038/sj.clpt.6100131
Details DOI PMID PMC WoS
-
2008 | Conference Abstract
Facilitation of the protein-protein interaction between CREB and its co-activator TORC (transducer of regulated CREB) by lithium
Heinrich, A.; Boeer, U.; Tzvetkov, M. V. & Knepel, W. (2008)
Naunyn-Schmiedeberg s Archives of Pharmacology, 377 49th Annual Meeting German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology, Mainz, GERMANY.
New york: Springer.
Details WoS
-
2008 | Journal Article
Functional characterization of a-100_-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B gene
Meineke, C.; Tzvetkov, M. V.; Bokelmann, K.; Oetjen, E.; Hirsch-Ernst, K. I.; Kaiser, R. & Brockmoeller, J. (2008)
Pharmacogenetics and Genomics, 18(3) pp. 219-230.
Details PMID PMC WoS
-
2008 | Journal Article
Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment
Tzvetkov, M. V.; Brockmoeller, J.; Roots, I. & Kirchheiner, J. (2008)
Pharmacogenetics and Genomics, 18(6) pp. 495-506.
Details PMID PMC WoS
-
2008 | Journal Article
A peroxisome proliferator-activated receptor gamma-retinoid X receptor heterodimer physically interacts with the transcriptional activator PAX6 to inhibit glucagon gene transcription
Kraetzner, R.; Froehlich, F.; Lepler, K.; Schroeder, M.; Roeher, K.; Dickel, C. & Tzvetkov, M. V. et al. (2008)
Molecular Pharmacology, 73(2) pp. 509-517. DOI: https://doi.org/10.1124/mol.107.035568
Details DOI PMID PMC WoS
-
2008 | Journal Article
Phytate utilization by genetically engineered lysine-producing Corynebacterium glutamicum
Tzvetkov, M. V. & Liebl, W. (2008)
Journal of Biotechnology, 134(3-4) pp. 211-217. DOI: https://doi.org/10.1016/j.jbiotec.2008.02.005
Details DOI PMID PMC WoS
-
2008 | Journal Article
Genetic polymorphisms of NAD(P)H oxidase: variation in subunit expression and enzyme activity
Schirmer, M. A.; Hoffmann, M.; Kaya, E.; Tzvetkov, M. V. & Brockmoeller, J. (2008)
The Pharmacogenomics Journal, 8(4) pp. 297-304. DOI: https://doi.org/10.1038/sj.tpj.6500467
Details DOI PMID PMC WoS
-
2008 | Review |
Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment
Brockmoeller, J.& Tzvetkov, M. V. (2008)
European Journal of Clinical Pharmacology, 64(2) pp. 133-157.
Heidelberg: Springer. DOI: https://doi.org/10.1007/s00228-007-0424-z
Details DOI PMID PMC WoS